Advanced Enzyme Technologies · NSE: ADVENZYMES · BSE: 540025
Q3 FY22 results · Oct–Dec 2021
Advanced Enzyme Technologies reported revenue from operations of ₹133.56 crore (down 3.0% from Q3 FY21) and net profit of ₹28.55 crore (down 35.5% from Q3 FY21) for Q3 FY22 (Oct–Dec 2021), on a consolidated basis.
| Item | Q3 FY22 | Q3 FY21 | YoY | Q2 FY22 | QoQ |
|---|---|---|---|---|---|
| Revenue from operations | 133.56 | 137.74 | −3.0% | 127.08 | +5.1% |
| Other income | 1.21 | 1.35 | −10.5% | 0.90 | +34.1% |
| Total income | 134.76 | 139.09 | −3.1% | 127.98 | +5.3% |
| Profit before tax | 41.12 | 60.91 | −32.5% | 41.24 | −0.3% |
| Net profit for the period | 28.55 | 44.30 | −35.5% | 30.27 | −5.7% |
| Attributable to shareholders of the company | 27.48 | 43.09 | −36.2% | — | — |
| EPS, basic (₹) | 2.46 | 3.86 | −36.3% | 2.66 | −7.5% |
| Net margin (%) | 21.4 | 32.2 | 23.8 |
| Item | Q3 FY22 | Q3 FY21 | YoY | Q2 FY22 | QoQ |
|---|---|---|---|---|---|
| Revenue from operations | 64.39 | 79.14 | −18.6% | 64.91 | −0.8% |
| Other income | 1.07 | 1.77 | −39.9% | 1.90 | −44.0% |
| Total income | 65.45 | 80.92 | −19.1% | 66.81 | −2.0% |
| Profit before tax | 11.78 | 26.42 | −55.4% | 17.25 | −31.7% |
| Net profit for the period | 8.77 | 20.32 | −56.8% | 12.84 | −31.7% |
| EPS, basic (₹) | 0.78 | 1.82 | −57.1% | 1.15 | not comparable |
| Net margin (%) | 13.6 | 25.7 | 19.8 |
Consolidated
- Filed with BSE
- 05 Feb 2022, 14:56 IST
- Board meeting
- 05 Feb 2022
- Period
- 01 Oct 2021 to 31 Dec 2021
- Review status
- Unaudited
- Source
- XBRL filing on BSE
Standalone
- Filed with BSE
- 05 Feb 2022, 14:56 IST
- Board meeting
- 05 Feb 2022
- Period
- 01 Oct 2021 to 31 Dec 2021
- Review status
- Unaudited
- Source
- XBRL filing on BSE